Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10495-013-0935-2.

Title:
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis | Apoptosis
Description:
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and the presence of a highly tumourigenic subpopulation of cancer cells called GBM stem cells. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising novel therapy for some treatment-resistant tumours but unfortunately GBM can be completely resistant to TRAIL monotherapy. In this study, we identified Mcl-1, an anti-apoptotic Bcl-2 family member, as a critical player involved in determining the sensitivity of GBM to TRAIL-induced apoptosis. Effective targeting of Mcl-1 in TRAIL resistant GBM cells, either by gene silencing technology or by treatment with R-roscovitine, a cyclin-dependent kinase inhibitor that targets Mcl-1, was demonstrated to augment sensitivity to TRAIL, both within GBM cells grown as monolayers and in a 3D tumour model. Finally, we highlight that two separate pathways are activated during the apoptotic death of GBM cells treated with a combination of TRAIL and R-roscovitine, one which leads to caspase-8 and caspase-3 activation and a second pathway, involving a Mcl-1:Noxa axis. In conclusion, our study demonstrates that R-roscovitine in combination with TRAIL presents a promising novel strategy to trigger cell death pathways in glioblastoma.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cells, trail, mcl, rroscovitine, cell, treatment, apoptosis, pubmed, article, google, scholar, cas, expression, gbm, fig, levels, noxa, death, treated, caspase, cancer, trailinduced, glioblastoma, tumour, activation, apoptotic, data, neurospheres, lines, resistance, bcl, ngml, observed, downregulation, control, protein, glioma, stem, percentage, proteins, knockdown, shrna, combination, expressed, panel, significant, central, study, targeting, signalling,

Topics {✒️}

tumour-necrosis factor superfamily serum-free neurosphere-forming medium quantitative real-time pcr r-roscovitine-induced inhibitory effects r-roscovitine + trail induces apoptosis death receptors dr4/trail-r1 cyclin-dependent kinase inhibitor r-roscovitine + trail-induced apoptosis dana-farber cancer institute egf/erbb1 signaling pathway article download pdf pe-conjugated secondary antibodies cellular flice-inhibitory protein vorinostat-induced apoptosis depends fitc-conjugated secondary antibodies r-roscovitine + trail significantly decreased override pro-inflammatory signalling stem cell-related “ water-insoluble mtt formazan inducing cell death glioblastoma-derived stem cells apoptosis-inducing effects gfp-expressing scramble control epidermal growth factor r-roscovitine-induced sensitisation establish trail-induced killing r-roscovitine-induced apoptosis r-roscovitine-mediated cflip downregulation establish trail-induced apoptosis annexin v-fitc conjugate trail-induced apoptosis mediated tumor cell repopulation related subjects r-roscovitine + trail treatment strategy trail-induced apoptotic signalling fibroblast growth factor trail-induced apoptosis—results bcl-2 family members anti-apoptotic protein mcl-1 survival-related genes trail-mediated mitochondrial apoptosis histone deacetylase inhibitors c-myc-mediated downregulation subsequent combined r-roscovitine human brain tumors full access death receptor signals western blot analysis induces cell death stem cell markers

Questions {❓}

  • Kuijlen JM et al (2010) Review: on TRAIL for malignant glioma therapy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
         description:Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and the presence of a highly tumourigenic subpopulation of cancer cells called GBM stem cells. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising novel therapy for some treatment-resistant tumours but unfortunately GBM can be completely resistant to TRAIL monotherapy. In this study, we identified Mcl-1, an anti-apoptotic Bcl-2 family member, as a critical player involved in determining the sensitivity of GBM to TRAIL-induced apoptosis. Effective targeting of Mcl-1 in TRAIL resistant GBM cells, either by gene silencing technology or by treatment with R-roscovitine, a cyclin-dependent kinase inhibitor that targets Mcl-1, was demonstrated to augment sensitivity to TRAIL, both within GBM cells grown as monolayers and in a 3D tumour model. Finally, we highlight that two separate pathways are activated during the apoptotic death of GBM cells treated with a combination of TRAIL and R-roscovitine, one which leads to caspase-8 and caspase-3 activation and a second pathway, involving a Mcl-1:Noxa axis. In conclusion, our study demonstrates that R-roscovitine in combination with TRAIL presents a promising novel strategy to trigger cell death pathways in glioblastoma.
         datePublished:2013-11-09T00:00:00Z
         dateModified:2013-11-09T00:00:00Z
         pageStart:629
         pageEnd:642
         sameAs:https://doi.org/10.1007/s10495-013-0935-2
         keywords:
            Glioblastoma
            TRAIL
            R-roscovitine
            Mcl-1
            Cancer Research
            Cell Biology
            Oncology
            Biochemistry
            general
            Virology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig6_HTML.gif
         isPartOf:
            name:Apoptosis
            issn:
               1573-675X
               1360-8185
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Á. C. Murphy
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. Weyhenmeyer
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Noonan
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. M. Kilbride
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Schimansky
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. P. Loh
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Kögel
               affiliation:
                     name:Johann Wolfgang Goethe University Hospital
                     address:
                        name:Experimental Neurosurgery, Centre for Neurology and Neurosurgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. G. Letai
               affiliation:
                     name:Harvard Medical School
                     address:
                        name:Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. H. M. Prehn
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. M. Murphy
               affiliation:
                     name:Royal College of Surgeons in Ireland
                     address:
                        name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
      description:Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and the presence of a highly tumourigenic subpopulation of cancer cells called GBM stem cells. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising novel therapy for some treatment-resistant tumours but unfortunately GBM can be completely resistant to TRAIL monotherapy. In this study, we identified Mcl-1, an anti-apoptotic Bcl-2 family member, as a critical player involved in determining the sensitivity of GBM to TRAIL-induced apoptosis. Effective targeting of Mcl-1 in TRAIL resistant GBM cells, either by gene silencing technology or by treatment with R-roscovitine, a cyclin-dependent kinase inhibitor that targets Mcl-1, was demonstrated to augment sensitivity to TRAIL, both within GBM cells grown as monolayers and in a 3D tumour model. Finally, we highlight that two separate pathways are activated during the apoptotic death of GBM cells treated with a combination of TRAIL and R-roscovitine, one which leads to caspase-8 and caspase-3 activation and a second pathway, involving a Mcl-1:Noxa axis. In conclusion, our study demonstrates that R-roscovitine in combination with TRAIL presents a promising novel strategy to trigger cell death pathways in glioblastoma.
      datePublished:2013-11-09T00:00:00Z
      dateModified:2013-11-09T00:00:00Z
      pageStart:629
      pageEnd:642
      sameAs:https://doi.org/10.1007/s10495-013-0935-2
      keywords:
         Glioblastoma
         TRAIL
         R-roscovitine
         Mcl-1
         Cancer Research
         Cell Biology
         Oncology
         Biochemistry
         general
         Virology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10495-013-0935-2/MediaObjects/10495_2013_935_Fig6_HTML.gif
      isPartOf:
         name:Apoptosis
         issn:
            1573-675X
            1360-8185
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Á. C. Murphy
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. Weyhenmeyer
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Noonan
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. M. Kilbride
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Schimansky
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. P. Loh
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Kögel
            affiliation:
                  name:Johann Wolfgang Goethe University Hospital
                  address:
                     name:Experimental Neurosurgery, Centre for Neurology and Neurosurgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. G. Letai
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. H. M. Prehn
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. M. Murphy
            affiliation:
                  name:Royal College of Surgeons in Ireland
                  address:
                     name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Apoptosis
      issn:
         1573-675X
         1360-8185
      volumeNumber:19
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Johann Wolfgang Goethe University Hospital
      address:
         name:Experimental Neurosurgery, Centre for Neurology and Neurosurgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
      name:Royal College of Surgeons in Ireland
      address:
         name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Á. C. Murphy
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:B. Weyhenmeyer
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:J. Noonan
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:S. M. Kilbride
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:S. Schimansky
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:K. P. Loh
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:D. Kögel
      affiliation:
            name:Johann Wolfgang Goethe University Hospital
            address:
               name:Experimental Neurosurgery, Centre for Neurology and Neurosurgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
               type:PostalAddress
            type:Organization
      name:A. G. Letai
      affiliation:
            name:Harvard Medical School
            address:
               name:Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:J. H. M. Prehn
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      name:B. M. Murphy
      affiliation:
            name:Royal College of Surgeons in Ireland
            address:
               name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Experimental Neurosurgery, Centre for Neurology and Neurosurgery, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany
      name:Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
      name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
      name:Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland

External Links {🔗}(225)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.63s.